Breast Cancer Incidence in Women Exposed to Estrogen and Estrogen-Progestin Replacement Therapy
Hormone replacement therapy (HRT) is widely used, mainly to relief vasomotor symptoms, but also for long-term protection against osteoporosis and cardiovascular disease. However, the alleged relationship between HRT and increased risk of postmenopausal breast cancer is of major concern. Since breast cancer is a frequent and serious disease, an association between HRT and an enhanced risk of breast cancer could cause a substantial number of new cases of or deaths from breast cancer. The aim of this presentation is to summarize briefly the available literature.
KeywordsBreast Cancer Relative Risk Breast Cancer Risk Hormone Replacement Therapy Estrogen Replacement Therapy
Unable to display preview. Download preview PDF.
- 1.Adami HO, Adams G, Boyle P, et al. (1990) Breast cancer etiology. Report from a working party for the Nordic Cancer Union Meeting, 1989. Int J Cancer 5:22–39.Google Scholar
- 2.Kelsey JL, Hildreth NG (1983) Breast and gynecologic cancer epidemiology CRC Press, Boca Raton, FL.Google Scholar
- 4.Boyle P (1988) Epidemiology of breast cancer. Bailliere’s Clinical Oncology 2:1–59.Google Scholar
- 29.UK National Case Control Study Group (1989) Oral contraceptive use and breast cancer risk in young women. Lancet 1:973–982.Google Scholar